The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care? James W. F. Catto Clinical Implications 05 October 2006 Pages: 883 - 885
Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications Lequn LiVassiliki A. Boussiotis Review 14 September 2006 Pages: 887 - 899
Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula Jan H. SchefeKerstin E. LehmannHeiko Funke-Kaiser Review 14 September 2006 Pages: 901 - 910
Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer Rui HenriqueVera Lúcia CostaCarmen Jerónimo Original Article 22 September 2006 Pages: 911 - 918
Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription Jan-Hendrik BebermeierJames D. BrooksPaul-Martin Holterhus Original Article 24 August 2006 Pages: 919 - 931
Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma Shu-Qun ShiLi XuJing-Pian Peng Original Article 05 August 2006 Pages: 933 - 941
Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor Maren ClausSusanne NeumannRalf Paschke Original Article 06 September 2006 Pages: 943 - 954
Patterns of association between PPARγ genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study Qi WeiDavid R. Jacobs Jr.Myriam Fornage Original Article 06 September 2006 Pages: 955 - 965
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway Chiara LaezzaGherardo MazziottiMaurizio Bifulco Original Article 01 September 2006 Pages: 967 - 973
Angiotensin II stimulates apoptosis via TGF-β1 signaling in ventricular cardiomyocytes of rat D. SchröderJ. HegerG. Euler Original Article 19 August 2006 Pages: 975 - 983
